  T11 Target structure (T11TS), a membrane glycoprotein isolated from sheep
erythrocytes, reverses the immune suppressed state of brain tumor induced
animals by boosting the functional status of the immune cells. This study aims
at aiding in the design of more efficacious brain tumor therapies with T11
target structure. We propose a mathematical model for brain tumor (glioma) and
the immune system interactions, which aims in designing efficacious brain tumor
therapy. The model encompasses considerations of the interactive dynamics of
macrophages, cytotoxic T lymphocytes, glioma cells, TGF-$\beta$, IFN-$\gamma$
and the T11TS. The system undergoes sensitivity analysis, that determines which
state variables are sensitive to the given parameters and the parameters are
estimated from the published data. Computer simulations were used for model
verification and validation, which highlight the importance of T11 target
structure in brain tumor therapy.
